End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
322,000 KRW | +1.74% | -1.53% | -8.65% |
May. 08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
May. 01 | Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8% | MT |
Chart calendar Hanmi Pharm. Co., Ltd.
Upcoming events on Hanmi Pharm. Co., Ltd.
Past events on Hanmi Pharm. Co., Ltd.
2024-05-02 | Non-Deal Roadshow |
2024-04-30 03:30 am | Q1 2024 Earnings Call |
2024-04-29 | Q1 2024 Earnings Release |
2024-04-03 12:30 am | Mirae Asset Global Healthcare Prescription Corporate Day |
2024-03-07 11:00 pm | Citi Korea Investor Conference |
2024-02-07 08:00 pm | SAMSUNG Healthcare Virtual Corporate Day |
2024-02-06 07:10 pm | Non Deal Roadshow |
2024-02-02 02:00 am | Q4 2023 Earnings Call |
2024-02-01 | Q4 2023 Earnings Release |
2023-11-07 07:10 pm | Non Deal Roadshow |
2023-11-02 08:20 pm | Non-Deal Roadshow |
2023-11-01 03:00 am | Q3 2023 Earnings Call |
2023-10-31 | Q3 2023 Earnings Release |
2023-09-20 08:30 pm | Kiwoom Securities Corporate Day |
2023-09-11 | KB Korea Conference |
2023-08-21 09:00 pm | KIS Global Investors Conference |
2023-07-27 | Q2 2023 Earnings Release |
2023-06-12 08:30 pm | NH Investment & Securities The C FORUM |
2023-05-10 08:20 pm | Roadshow |
2023-05-03 08:10 pm | Roadshow - Meritz Securities |
Past dividends on Hanmi Pharm. Co., Ltd.
2023-12-26 | Annual 500 KRW |
2022-12-27 | Annual 500 KRW |
2021-12-28 | Annual 500 KRW |
2020-12-28 | Annual 500 KRW |
2019-12-26 | Annual 500 KRW |
2018-12-26 | Annual 500 KRW |
2017-12-26 | Annual 500 KRW |
2015-12-28 | Annual 2000 KRW |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 1 114 1 111 0.19% | 1 076 1 108 -2.86% | 1 206 1 157 4.21% | 1 332 1 342 -0.8% | 1 491 1 468 1.54% | 1 635 |
EBITDA Billions KRW | Released Forecast Spread | 159 151 5.24% | 110 106 4.53% | 215 190 12.68% | 255 244 4.68% | 319 307 3.89% | 354 |
EBIT Billions KRW | Released Forecast Spread | 104 93,5 11.18% | 48,7 47,8 1.81% | 127 112 13.45% | 157 156 0.62% | 221 212 4.13% | 261 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 83,3 76,2 9.29% | 22,1 12,9 71.68% | 104 99,0 4.84% | 117 138 -15.11% | 194 192 1.21% | 241 |
Net income Billions KRW | Released Forecast Spread | 52,1 45,4 14.78% | 12,0 3,08 288.46% | 81,1 68,3 18.69% | 76,9 93,1 -17.42% | 159 140 14.1% | 177 |
EPS KRW | Released Forecast Spread | 4 170 3 543 17.7% | 939 236 298.29% | 5 270 5 356 -1.6% | 7 994 6 958 14.89% | 11 522 11 182 3.04% | 14 006 |
Announcement Date | 07/02/20 | 04/02/21 | 27/01/22 | 08/02/23 | 02/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Billions KRW | Released Forecast Spread | 350 319 9.86% | 321 307 4.52% | 317 308 2.87% | 342 327 4.58% | 351 367 -4.16% | 362 360 0.38% | 343 347 -1.35% | 365 369 -1.29% | 422 402 5% | 404 401 0.59% | 386 | 400 | 440 | 423 |
EBITDA Billions KRW | Released Forecast Spread | 54,5 42,6 27.87% | 72,7 56,9 27.84% | 64,1 59,0 8.65% | 84,6 76,0 11.28% | 57,8 70,0 -17.38% | 78,0 | 94,7 65,3 45.05% | 94,8 | 74,1 | 85,6 | 74,3 | |||
EBIT Billions KRW | Released Forecast Spread | 42,7 35,2 21.49% | 38,7 34,1 13.37% | 29,6 23,0 28.77% | 46,8 39,5 18.61% | 37,8 40,3 -6.32% | 60,5 50,6 19.55% | 33,2 37,5 -11.6% | 57,5 51,9 10.89% | 70,1 64,9 7.95% | 76,6 67,6 13.31% | 50,6 | 58,9 | 68,6 | 70,1 |
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 34,1 27,6 23.52% | 35,7 27,4 30.19% | 26,4 22,5 17.36% | 37,9 35,3 7.22% | 16,6 36,7 -54.75% | 55,6 49,1 13.4% | 25,4 30,4 -16.43% | 56,3 47,7 18.09% | 56,9 58,4 -2.61% | 75,0 70,4 6.5% | 51,7 | 48,6 | 59,8 | 72,1 |
Net income Billions KRW | Released Forecast Spread | 17,5 17,3 1.17% | 19,3 21,0 -8.06% | 18,0 14,8 21.47% | 25,4 24,4 4.21% | 13,6 25,8 -47.16% | 43,1 30,6 40.88% | 16,1 21,0 -23.54% | 54,7 32,7 67.31% | 47,4 39,8 19.32% | 55,0 51,3 7.29% | 38,2 | 32,0 | 41,8 | 37,7 |
Announcement Date | 27/01/22 | 27/04/22 | 18/07/22 | 01/11/22 | 08/02/23 | 26/04/23 | 28/07/23 | 01/11/23 | 02/02/24 | 30/04/24 | - | - | - | - |
Past sector events for Hanmi Pharm. Co., Ltd.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A128940 Stock
- Calendar Hanmi Pharm. Co., Ltd.